| 000 | 01766 a2200541 4500 | ||
|---|---|---|---|
| 005 | 20250517121149.0 | ||
| 264 | 0 | _c20170302 | |
| 008 | 201703s 0 0 eng d | ||
| 022 | _a2287-285X | ||
| 024 | 7 |
_a10.3350/cmh.2016.0047 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLee, Han Ah | |
| 245 | 0 | 0 |
_aHepatitis B surface antigen titer is a good indicator of durable viral response after entecavir off-treatment for chronic hepatitis B. _h[electronic resource] |
| 260 |
_bClinical and molecular hepatology _cSep 2016 |
||
| 300 |
_a382-389 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAlanine Transaminase _xblood |
| 650 | 0 | 4 |
_aAntiviral Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aDNA, Viral _xblood |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 |
_aGuanine _xanalogs & derivatives |
| 650 | 0 | 4 |
_aHepatitis B Surface Antigens _xblood |
| 650 | 0 | 4 |
_aHepatitis B virus _xgenetics |
| 650 | 0 | 4 |
_aHepatitis B, Chronic _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aMultivariate Analysis |
| 650 | 0 | 4 | _aPolymerase Chain Reaction |
| 650 | 0 | 4 | _aRecurrence |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aSeo, Yeon Seok | |
| 700 | 1 | _aPark, Seung Woon | |
| 700 | 1 | _aPark, Sang Jung | |
| 700 | 1 | _aKim, Tae Hyung | |
| 700 | 1 | _aSuh, Sang Jun | |
| 700 | 1 | _aJung, Young Kul | |
| 700 | 1 | _aKim, Ji Hoon | |
| 700 | 1 | _aAn, Hyunggin | |
| 700 | 1 | _aYim, Hyung Joon | |
| 700 | 1 | _aYeon, Jong Eun | |
| 700 | 1 | _aByun, Kwan Soo | |
| 700 | 1 | _aUm, Soon Ho | |
| 773 | 0 |
_tClinical and molecular hepatology _gvol. 22 _gno. 3 _gp. 382-389 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3350/cmh.2016.0047 _zAvailable from publisher's website |
| 999 |
_c26505805 _d26505805 |
||